Condition
Intravitreal Injections
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed2
Recruiting2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07481500Not ApplicableNot Yet Recruiting
Speculum-Free Intravitreal Injection Using Cotton-Tipped Applicator Retraction: A Randomized Trial of Pain, Procedure Time, Patient Satisfaction, and Safety
NCT06810011RecruitingPrimary
Eye Diseases "Treated" with Interoperable Medical Informatics
NCT02669953Recruiting
Aflibercept in Recurrent or Persistent CNV
NCT04343222Phase 4CompletedPrimary
Control of Pain in Intravitreal Injections Using Topical NSAIDs
NCT00702039CompletedPrimary
Effect of Music Therapy on Patients Undergoing Intravitreal Injections
Showing all 5 trials